As SLE is characterized by a prominent expression of IFN-stimulated genes in 50%-75% of adult patients, this disease was of highest interest to assess whether the pathology involves a dysregulated IFNα–TNFα crosstalk (43). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.